To test the effects of rhIL-7-hyFc (Fig. 1a) on CAR T cells in vitro, human TCR-deficient anti-CD19 CAR T cells (UCART19) were cultured with rhIL-7-hyFc in the presence of CD19+ tumor cells. The gene discussed is CD19; the disease is neoplasm.